Jean-Yves Pierga - JoVE Visualize

Showing results (31-40 of 244) with videos related to

Pageof 25

Sort By:

Plos One|July 28, 2015

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.

Journal of Visualized Experiments : Jove|October 16, 2018

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot RegionsCharles Decraene, Amanda Bortolini Silveira, Marc Michel, et al.

American Journal of Clinical Oncology|August 8, 2025

Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast CancerAssile El Fakih, Pierre Loap, Luc Cabel, et al.

Oncogene|September 15, 2019

ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.

Breast Cancer Research : BCR|August 21, 2004

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceValérie Choesmel, Jean-Yves Pierga, Claude Nos, et al.

Bulletin Du Cancer|January 7, 2005

[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]Patricia de Cremoux, Véronique Diéras, Marie-France Poupon, et al.

Journal of Extracellular Biology|June 28, 2024

Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancerMercedes Tkach, Caroline Hego, Marc Michel, et al.

Expert Review of Molecular Diagnostics|November 17, 2015

Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisionsAdrien Saliou, François-Clément Bidard, Olivier Lantz, et al.

Nature Reviews. Clinical Oncology|July 28, 2018

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.

American Journal of Clinical Oncology|July 16, 2024

Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.

Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:

Pageof 25

Plos One|July 28, 2015

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationLea Rossi, Denise Stevens, Jean-Yves Pierga, et al.

Journal of Visualized Experiments : Jove|October 16, 2018

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot RegionsCharles Decraene, Amanda Bortolini Silveira, Marc Michel, et al.

American Journal of Clinical Oncology|August 8, 2025

Real-world Safety of Concurrent Pembrolizumab and Radiotherapy in Triple-negative Breast CancerAssile El Fakih, Pierre Loap, Luc Cabel, et al.

Oncogene|September 15, 2019

ERBB3 mutations in cancer: biological aspects, prevalence and therapeuticsNicolas Kiavue, Luc Cabel, Samia Melaabi, et al.

Breast Cancer Research : BCR|August 21, 2004

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevanceValérie Choesmel, Jean-Yves Pierga, Claude Nos, et al.

Bulletin Du Cancer|January 7, 2005

[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]Patricia de Cremoux, Véronique Diéras, Marie-France Poupon, et al.

Journal of Extracellular Biology|June 28, 2024

Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancerMercedes Tkach, Caroline Hego, Marc Michel, et al.

Expert Review of Molecular Diagnostics|November 17, 2015

Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisionsAdrien Saliou, François-Clément Bidard, Olivier Lantz, et al.

Nature Reviews. Clinical Oncology|July 28, 2018

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.

American Journal of Clinical Oncology|July 16, 2024

Concurrent Use of Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: A Single-center Experience and Review of the LiteratureJihane Bouziane, Pierre Loap, Kim Cao, et al.

Pageof 25